Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Frontiers in Public Health|July 28, 2026
Teaching stool form recognition in primary school: multimedia versus paper-based instruction using the Bristol stool form scaleChia-Jen Lee, Yung-Jen Yang, Ying-Jyun Shih, et al.
Anticancer Research|July 2, 2014
Antitumor activity of acriflavine in human hepatocellular carcinoma cellsChia-Jen Lee, Chia-Herng Yue, Yu-Yu Lin, et al.
Anticancer Research|December 1, 2021
Cetyltrimethylammonium Bromide Disrupts Mesenchymal Characteristics of Human Tongue Squamous Cell Carcinoma SCC4 Cells Through Modulating Canonical TGF-β/Smad/miR-181b/TIMP3 Signaling PathwayChia-Herng Yue, Chung-Hung Chen, Ying-Ru Pan, et al.
Anticancer Research|July 20, 2021
Cetyltrimethylammonium Bromide Attenuates the Mesenchymal Characteristics of Hypopharyngeal Squamous Cell Carcinoma Through Inhibiting the EGFR/PI3K/AKT Signaling PathwayTsai-Kun Wu, Yen-Chuan Ou, Yi-Ping Chen, et al.
Anticancer Research|November 5, 2014
Antitumor activity of acriflavine in lung adenocarcinoma cell line A549Chia-Jen Lee, Chia-Herng Yue, Yu-Jie Lin, et al.
Anticancer Research|March 31, 2018
Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition via Down-regulation of EGFR Pathway in MDA-MB-231 cellsJi-Kuen Yu, Chia-Herng Yue, Ying-Ru Pan, et al.
Anticancer Research|September 4, 2020
Cetyltrimethylammonium Bromide Suppresses the Migration and Invasion of Hepatic Mahlavu Cells by Modulating Fibroblast Growth Factor SignalingTsai-Kun Wu, Chung-Hung Chen, Wei-Ting Lee, et al.
Anticancer Research|July 3, 2019
Cetrimonium Bromide Inhibits Cell Migration and Invasion of Human Hepatic SK-HEP-1 Cells Through Modulating the Canonical and Non-canonical TGF-β Signaling PathwaysTsai-Kun Wu, Chung-Hung Chen, Ying-Ru Pan, et al.
The American Journal of Chinese Medicine|July 31, 2015
Anemone altaica Induces Apoptosis in Human Osteosarcoma CellsI-Chang Chang, Tsay-I Chiang, Chun Lo, et al.
Journal of Cancer|September 21, 2017
MZF-1/Elk-1/PKCα is Associated with Poor Prognosis in Patients with Hepatocellular CarcinomaJe-Chiuan Ye, Li-Sung Hsu, Jen-Hsiang Tsai, et al.
Pageof 2